Oxford Immunotec Global PLC Announces Board Appointments, Effective from November 4, 2015
Mr. Andrews most recently served as President of the Genetic Sciences Division of Thermo Fisher Scientific, a position he assumed upon Thermo Fisher's acquisition of Life Technologies Corporation, where he had been the President of the Medical Sciences Venture. Following the acquisition, Mr. Andrews led the integration of Life Technologies' next generation sequencing technology into the Thermo Fisher product line. Mr. Walton is currently the Chief Executive Officer of Ameritox.